Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities
- PMID: 40694958
- PMCID: PMC12304726
- DOI: 10.1016/j.redox.2025.103776
Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities
Abstract
Polycystic ovary syndrome (PCOS), a common yet intricate endocrine disorder, presents persistent clinical challenges due to its complex pathogenesis. Reactive oxygen species (ROS), highly reactive molecules, have emerged as critical contributors to PCOS development and represent potential therapeutic targets. This review comprehensively explores the diverse roles of ROS in PCOS pathogenesis, particularly their contributions to metabolic dysfunction and hormonal imbalance. It further assesses the therapeutic potential of ROS-targeted interventions, summarizing antioxidant therapy advancements, underlying mechanisms, and current challenges. By consolidating recent research, this review highlights the profound significance of ROS in PCOS, aiming to inspire innovative pathogenesis research, improve clinical management, and establish a robust theoretical foundation for more effective PCOS treatment strategies.
Keywords: Metabolism; Polycystic ovary syndrome; Reactive oxygen species; Targets.
Copyright © 2025. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Mechanistic insight into nanomedicine for polycystic ovary syndrome.Mol Biol Rep. 2025 Jun 21;52(1):618. doi: 10.1007/s11033-025-10709-7. Mol Biol Rep. 2025. PMID: 40544202 Review.
-
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: the impact of androgen excess on metabolic health.Reproduction. 2025 Jul 4;170(2):e250102. doi: 10.1530/REP-25-0102. Print 2025 Aug 1. Reproduction. 2025. PMID: 40548832 Review.
-
Evaluating serum anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women.Int J Gynaecol Obstet. 2025 Jun 25. doi: 10.1002/ijgo.70240. Online ahead of print. Int J Gynaecol Obstet. 2025. PMID: 40560122
-
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2016 Dec;31(12):2841-2855. doi: 10.1093/humrep/dew218. Epub 2016 Sep 22. Hum Reprod. 2016. PMID: 27664216
-
Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome.Clin Chim Acta. 2025 Aug 15;576:120425. doi: 10.1016/j.cca.2025.120425. Epub 2025 Jun 12. Clin Chim Acta. 2025. PMID: 40516895 Review.
References
-
- Hajam Y.A., Rather H.A., Neelam, Kumar R., Basheer M., Reshi M.S. A review on critical appraisal and pathogenesis of polycystic ovarian syndrome. Endocrine Metabol. Sci. 2024;14 doi: 10.1016/j.endmts.2024.100162. - DOI
-
- Bhattacharya K., Dey R., Sen D., Paul N., Basak A.K., Purkait M.P., Shukla N., Chaudhuri G.R., Bhattacharya A., Maiti R., Adhikary K., Chatterjee P., Karak P., Syamal A.K. Polycystic ovary syndrome and its management: in view of oxidative stress. Biomol. Concepts. 2024;15 doi: 10.1515/bmc-2022-0038. - DOI - PubMed
-
- Yan H., Wang L., Zhang G., Li N., Zhao Y., Liu J., Jiang M., Du X., Zeng Q., Xiong D., He L., Zhou Z., Luo M., Liu W. Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reprod. Biol. Endocrinol. 2024;22:159. doi: 10.1186/s12958-024-01337-0. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources